Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Mary A. Katofiasc"'
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 101:171-179
The feasibility of eliciting defecation and urination after intranasal (IN) or sublingual (SL) delivery of a small peptide NK2 receptor agonist, [Lys5, MeLeu9, Nle10]-NKA(4–10), was examined using prototype formulations in dogs. In anesthetized ani
Publikováno v:
J Neurotrauma
Acute administration of [Lys5,Me,Leu9,Nle10]-NKA(4-10) (LMN-NKA) produces contractions of the detrusor and rectum with voiding in intact and acutely spinal cord injured (SCI) rats. In the current study, the ability of LMN-NKA (10 μg/kg or 100 μg/kg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b624531955c535c2e072c1fa03c76f84
https://europepmc.org/articles/PMC7071061/
https://europepmc.org/articles/PMC7071061/
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 391:907-914
The effects of the tachykinin NK2 receptor agonist LMN-NKA ([Lys5,MeLeu9,Nle10]-NKA(4-10)) on colorectal and arterial blood pressure were examined in anesthetized macaques. Intravenous (IV) administration of 1–100 μg/kg caused dose-related increas
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 366:136-144
Tachykinin neurokinin 2 (NK2) receptor agonists may have potential to alleviate clinical conditions associated with bladder and gastrointestinal underactivity by stimulating contraction of visceral smooth muscle. The ability of [Lys5,MeLeu9,Nle10]-ne
Autor:
Nadia M J, Rupniak, Mary A, Katofiasc, Lesley, Marson, Daniel J, Ricca, Karl B, Thor, Edward C, Burgard
Publikováno v:
Neuropeptides
The effects of the neurokinin NK2 receptor agonist [Lys(5),MeLeu(9),Nle(10)]-NKA((4–10)) (LMN-NKA) on bladder and colorectal function were examined in minipigs. In anesthetized animals, subcutaneous (SC) administration of 30–100 μg/kg increased
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 390:163-173
The purpose of this study was to determine feasibility of a novel therapeutic approach to drug-induced voiding after spinal cord injury (SCI) using a well-characterized, peptide, neurokinin 2 receptor (NK2 receptor) agonist, Lys5, MeLeu9, Nle10-NKA(4
The suitability of various neurokinin-2 (NK2) receptor agonists and routes of administration to elicit on-demand voiding of the bladder and bowel, as future therapy for individuals with spinal cord injury, was examined using a rat model. The current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e75a3f7fad13bc19bda5fb99347a5b5
https://europepmc.org/articles/PMC5766413/
https://europepmc.org/articles/PMC5766413/
Autor:
Daniel J. Ricca, Karl B. Thor, Nadia M.J. Rupniak, Mary A. Katofiasc, Edward C. Burgard, Lesley Marson
Publikováno v:
Neuropeptides. 77:101956
The effects of the neurokinin NK2 receptor agonist [Lys5,MeLeu9,Nle10]-NKA(4–10) (LMN-NKA) on bladder and colorectal function were examined in minipigs. In anesthetized animals, subcutaneous (SC) administration of 30–100 μg/kg increased peak bla
Publikováno v:
Gastroenterology. 156:S-359
Autor:
Ken H. Ho, Edward L. Mattiuz, Ann Marie L. Ogden, Brian Michael Mathes, Ana I. Mateo, David Bleakman, Kevin John Hudziak, Donna K. Dieckman, Sandra Ann Filla, Mark A. Winter, Thomas J. Bleisch, Ana Maria Escribano, Paul L. Ornstein, Kirk W. Johnson, Douglas Richard Stack, Amy Clemens-Smith, Miriam del Prado, Ana M. Castaño, Mary A. Katofiasc, Robert E. Stratford, E. Dominguez, Michael Gregory Bell, Lee A. Phebus, Jose A. Martinez-Perez
Publikováno v:
Journal of Medicinal Chemistry. 45:4383-4386
Amino diacid 3, a highly selective competitive GluR5 kainate receptor antagonist, exhibited high GluR5 receptor affinity and selectivity over other glutamate receptors. Its diethyl ester prodrug 4 was orally active in two models of migraine: the neur